Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Life Sciences|December 26, 2021
A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myelomaRebecca Amet, Viola Previtali, Helene B Mihigo, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Synthesis and Biochemical Evaluation of Ethanoanthracenes and Related Compounds: Antiproliferative and Pro-Apoptotic Effects in Chronic Lymphocytic Leukemia (CLL)James P McKeown, Andrew J Byrne, Sandra A Bright, et al.
Cancer Research|October 15, 2009
The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemiaAnthony M McElligott, Elaina N Maginn, Lisa M Greene, et al.
Plos One|April 20, 2026
Upregulation of CD1d and ULBP3 on B cells from healthy donors and chronic lymphocytic leukaemia patients does not prime them for killing by γδ T cellsJulie David, Amy Walsh, Ke Sin Seow, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 25, 2026
Impact of CD19 CAR T-Cell Therapy on Pathogen-Specific Antibody Titers in Lymphoma PatientsHayley Foy-Stones, Nicola Gardiner, Ellen Walsh, et al.
European Journal of Haematology|July 1, 2022
Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high-risk features and reduced treatment-free-intervalsSmyth Elizabeth, Kelly Aidan, O' Brien David, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 12, 2010
The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistanceLisa M Greene, Seema M Nathwani, Sandra A Bright, et al.
Cancer Letters|January 4, 2025
Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancerMadison T Hindes, Anthony M McElligott, Oliver G Best, et al.
Pageof 2